TxCell: Board ahoy
Immunotherapy maker TxCell SA has appointed gene therapy expert Olivier Danos to its newly founded Scientific Advisory Board. Danos serves as Senior Vice President of Cell and Gene Therapy at Biogen and has led Biogens gene therapy research group for the last two years. Previously, Danos served as Senior VP Molecular Medicine, Synthetic Biology and Gene Regulation at Kadmon Pharmaceuticals.
Prior to that, he was the Director of the Gene Therapy Consortium at University College, London, and led a gene therapy research team at the Necker Hospital in Paris. His other previous appointments include Scientific Director of Généthon and Senior Research Director with the CNRS in France.
NOD-Proteindesign.Andreas Heddergott/TUM.jpg
Certest
Consilium